Skip to main content

. 1984 Jun;17(6):781–782. doi: 10.1111/j.1365-2125.1984.tb02420.x

No detectable concentrations of oxmetidine but measurable concentrations of cimetidine in cerebrospinal fluid (CSF) during multiple dose treatment.

K A Jönsson, S E Eriksson, I Kagevi, B Norlander, G Bodemar, A Walan

PMCID: PMC1463420 PMID: 6743472

781

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Jönsson K. A., Eriksson S. E., Kagevi I., Norlander B., Bodemar G., Walan A. Cimetidine, but not oxmetidine, penetrates into the cerebrospinal fluid after a single intravenous dose. Br J Clin Pharmacol. 1982 Dec;14(6):815–819. doi: 10.1111/j.1365-2125.1982.tb02042.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Larsson R., Bodemar G., Kågedal B. The effect of cimetidine, a new histamine H2-receptor antagonist, on renal function. Acta Med Scand. 1979;205(1-2):87–89. doi: 10.1111/j.0954-6820.1979.tb06008.x. [DOI] [PubMed] [Google Scholar]
Larsson R., Erlanson P., Bodemar G., Walan A., Bertler A., Fransson L., Norlander B. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. Br J Clin Pharmacol. 1982 Feb;13(2):163–170. doi: 10.1111/j.1365-2125.1982.tb01351.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tibbling G., Link H., Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977 Sep;37(5):385–390. doi: 10.1080/00365517709091496. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES